AstraZeneca shares plunge as Wainua fails late-stage heart disease trial
Covered by 2 sources · 2 articles
2 outlets - including Wsj and Invezz - are covering this story. AstraZeneca shares slumped nearly 10% on Thursday after the drugmaker said its nerve disease treatment Wainua failed to achieve the primary objective in a late-stage clinical trial for a serious heart condition, dealing a setback to one of…
All coverage
AstraZeneca, Ionis Shares Slide After Wainua Misses Target in Heart Disease Trial
AstraZeneca shares plunge as Wainua fails late-stage heart disease trial
AstraZeneca shares slumped nearly 10% on Thursday after the drugmaker said its nerve disease treatment Wainua failed to achieve the primary objective in a late-stage clinical trial for a serious heart condition, dealing a setback to one of…